Les essais contrôlés randomisés. Une comparaison entre la médecine et l’économie

Arthur Jatteau ()

Post-Print from HAL

Abstract: Since the beginning of the 2000s, Randomized Controlled Trials (RCTs) have returned to center stage, both in the economics of development and in the evaluation of public policy. Despite the fact that RCT promoters claim a filiation with medicine, these economists seem unfamiliar with the literature around clinical trials. This article aims to overcome this limitation, by comparing the use and the limits of RCTs between medicine and economics. I show that while this method is considered to be the "gold standard" of evidence in medicine, some limits exist and have to be taken into account in economics. I also show how the way in which the problem of external validity is addressed in medicine provides arguments to obtain a more nuanced picture of the interest of RCTs in economics.

Date: 2019-05-24
References: Add references at CitEc
Citations: Track citations by RSS feed

Published in Philosophia Scientae, 2019, Philosophia Scientae, 23 (2), pp.85-110. ⟨10.4000/philosophiascientiae.1933⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02563206

DOI: 10.4000/philosophiascientiae.1933

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().